US Map / New Mexico
State NM

Clinical Trials in New Mexico

Recruiting clinical trials with at least one study location in New Mexico. Data updated daily from ClinicalTrials.gov.

Total Trials
63
Recruiting Now
63
← Back to US Map
Top Conditions in New Mexico
Chronic Lymphocytic Leukemia (3)Head and Neck Squamous Cell Carcinoma (2)Small Lymphocytic Lymphoma (2)Head and Neck Carcinoma (2)Breast Cancer (2)RISS Stage I Plasma Cell Myeloma (2)RISS Stage II Plasma Cell Myeloma (2)Acute Myeloid Leukemia (2)Opioid Use Disorder (2)Atrial Fibrillation (2)Non-small Cell Lung Cancer (1)Primary Biliary Cholangitis (PBC) (1)

Frequently Asked Questions — Clinical Trials in New Mexico

How many clinical trials are currently recruiting in New Mexico?
ClinicalMetric currently tracks 63 actively recruiting clinical trials with at least one location in New Mexico. The total number of registered studies—including active but not currently enrolling trials—is 63. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Mexico?
New Mexico hosts clinical trials across a broad range of medical conditions, including Chronic Lymphocytic Leukemia, Head and Neck Squamous Cell Carcinoma, Small Lymphocytic Lymphoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Mexico serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Mexico?
To join a clinical trial in New Mexico, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Mexico maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in New Mexico

NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
View Trial →
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT02915198 Phase 4
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuT...
Condition
Prediabetic State
Enrollment
7,410 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06940609 Phase 2
Recruiting
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulat...
Condition
Long COVID
Enrollment
60 pts
Location
United States
Sponsor
University of New Mexico
View Trial →
NCT03943316 N/A
Recruiting
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Pat...
Condition
Ovarian Cancer
Enrollment
100 pts
Location
United States
Sponsor
New Mexico Cancer Research All
View Trial →
NCT06516952 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participant...
Condition
Prurigo Nodularis
Enrollment
330 pts
Location
United States, Argentina, Austria
Sponsor
Incyte Corporation
View Trial →
NCT05787821 N/A
Recruiting
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Condition
Knee Pain Chronic
Enrollment
760 pts
Location
United States
Sponsor
Zimmer Biomet
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT04064359 Phase 1
Recruiting
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid T...
Condition
Solid Tumor
Enrollment
200 pts
Location
United States, Belgium, France
Sponsor
Oxford BioTherapeutics Ltd
View Trial →
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT02986984 N/A
Recruiting
Transformative Research in Diabetic Nephropathy
Condition
Diabetic Nephropathies
Enrollment
400 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07281430 N/A
Recruiting
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Tri...
Condition
Cervical Carcinoma
Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06581432 Phase 2
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanc...
Condition
Solid Tumours
Enrollment
430 pts
Location
United States, Australia, Belgium
Sponsor
Boehringer Ingelheim
View Trial →
NCT06423664 N/A
Recruiting
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposu...
Condition
Developmental Delay
Enrollment
20 pts
Location
United States
Sponsor
IDeA States Pediatric Clinical
View Trial →
NCT04130516 Phase 1, Phase 2
Recruiting
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801a...
Condition
Solid Tumor, Adult
Enrollment
200 pts
Location
United States
Sponsor
Linnaeus Therapeutics, Inc.
View Trial →
NCT06500702 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzab...
Condition
Focal Segmental Glomerulosclerosis
Enrollment
84 pts
Location
United States, Argentina, Australia
Sponsor
Sanofi
View Trial →
NCT03556228 Phase 1, Phase 2
Recruiting
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpr...
Condition
Head and Neck Carcinoma
Enrollment
242 pts
Location
United States, Puerto Rico
Sponsor
VM Oncology, LLC
View Trial →
NCT04373317 Phase 4
Recruiting
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Condition
Parkinson's Disease Psychosis
Enrollment
358 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05434234 Phase 1, Phase 2
Recruiting
A Study of YL201 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
312 pts
Location
United States, Canada, China
Sponsor
MediLink Therapeutics (Suzhou)
View Trial →
Page 1 of 3 — 63 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology